Francesco Pegoraro

21PUBLICATIONS
111CO-AUTHORS
Gene and molecular therapyCardiovascular medicine and haematology not elsewhere classifiedCardiology (incl. cardiovascular diseases)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 01, 2026
Longitudinal Monocyte Subset Dynamics as Biomarker in Adult Histiocytosis: Association With Mutational Status, Kinase Inhibitor Exposure and Relapse Risk.

|Jun 19, 2026
Glomeruloid haemangioma in Erdheim-Chester disease: An atypical skin manifestation associated with elevated vascular endothelial growth factor-A levels.

|Jun 09, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for Histiocytosis.

|Mar 25, 2026
Predisposition to ALL and Solid Tumors Rather Than Bone Marrow Failure in FANCM-Associated Fanconi Anemia.

Francesco Pegoraro, Lise Larcher, Rathana Kim

|Feb 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study of 288 patients.

Jean Donadieu, Dmitry Evseev, Francesco Pegoraro

|Nov 08, 2025
Real-Life Efficacy and Safety of BRAF Inhibitors in Erdheim-Chester Disease.

Francesco Pegoraro, Francesco Peyronel, Matthias Papo

Pageof 4

Frequent Collaborators

6 joint publications

Jean-François Emile

5 joint publications

Augusto Vaglio

5 joint publications

Francesco Catamerò

5 joint publications

Elena Sieni